Logan Capital Management’s Quest Diagnostics DGX Stock Holding History

Logan Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06K	Buy	+5	New	+$981	﹤0.01%	410
2025 Q4	–	Sell	-5	Closed	-$953	–	313
2025 Q3	$953	Hold	5	–	–	﹤0.01%	433
2025 Q2	$898	Sell	5 -4	-44%	-$695	﹤0.01%	432
2025 Q1	$1.52K	Buy	9 +1	+13%	+$164	﹤0.01%	494
2024 Q4	$1.21K	Hold	8	–	–	﹤0.01%	475
2024 Q3	$1.24K	Hold	8	–	–	﹤0.01%	454
2024 Q2	$1.09K	Buy	+8	New	+$1.1K	﹤0.01%	443
2021 Q4	–	Sell	-600	Closed	-$87K	–	547
2021 Q3	$87K	Hold	600	–	–	﹤0.01%	327
2021 Q2	$79K	Hold	600	–	–	﹤0.01%	327
2021 Q1	$77K	Buy	+600	New	+$73.9K	﹤0.01%	321
2016 Q2	–	Sell	-3,600	Closed	-$257K	–	269
2016 Q1	$257K	Hold	3,600	–	–	0.02%	272
2015 Q4	$256K	Hold	3,600	–	–	0.02%	266
2015 Q3	$221K	Hold	3,600	–	–	0.02%	272
2015 Q2	$261K	Hold	3,600	–	–	0.02%	281
2015 Q1	$277K	Hold	3,600	–	–	0.02%	252
2014 Q4	$241K	Hold	3,600	–	–	0.02%	262
2014 Q3	$218K	Hold	3,600	–	–	0.02%	258
2014 Q2	$211K	Hold	3,600	–	–	0.01%	261
2014 Q1	$209K	Buy	+3,600	New	+$193K	0.02%	259
2013 Q4	–	Sell	-3,600	Closed	-$222K	–	274
2013 Q3	$222K	Hold	3,600	–	–	0.02%	252
2013 Q2	$216K	Buy	+3,600	New	+$214K	0.02%	241

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Logan Capital Management's DGX Position: Q2 2026 in Review

Logan Capital Management opened a new position in Quest Diagnostics (DGX) in Q2 2026: 5 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #410 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in DGX as recently as Q3 2025.

Logan Capital Management first reported a position in DGX in Q2 2013 and has held it in 21 quarters since. The position peaked at $277K in Q1 2015. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Logan Capital Management held 5 shares of Quest Diagnostics worth $1.06K as of Q2 2026.
Quest Diagnostics was a new Logan Capital Management position in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Logan Capital Management's portfolio in Q2 2026, its #410 holding.
Logan Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 21 quarters since.
Logan Capital Management's Quest Diagnostics position peaked at $277K in Q1 2015.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.